nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—OPRD1—epilepsy syndrome	0.131	0.485	CbGaD
Dextropropoxyphene—OPRM1—epilepsy syndrome	0.1	0.371	CbGaD
Dextropropoxyphene—CYP2D6—epilepsy syndrome	0.0388	0.144	CbGaD
Dextropropoxyphene—Phenylbutazone—Fosphenytoin—epilepsy syndrome	0.0348	0.121	CrCrCtD
Dextropropoxyphene—Phenylbutazone—Phenytoin—epilepsy syndrome	0.0238	0.083	CrCrCtD
Dextropropoxyphene—Modafinil—Fosphenytoin—epilepsy syndrome	0.0213	0.0743	CrCrCtD
Dextropropoxyphene—Antazoline—Phenytoin—epilepsy syndrome	0.0198	0.0688	CrCrCtD
Dextropropoxyphene—Phenylbutazone—Clobazam—epilepsy syndrome	0.0194	0.0677	CrCrCtD
Dextropropoxyphene—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.0149	0.0517	CrCrCtD
Dextropropoxyphene—Modafinil—Phenytoin—epilepsy syndrome	0.0146	0.0509	CrCrCtD
Dextropropoxyphene—Trimipramine—Carbamazepine—epilepsy syndrome	0.0135	0.047	CrCrCtD
Dextropropoxyphene—Modafinil—Carbamazepine—epilepsy syndrome	0.0135	0.047	CrCrCtD
Dextropropoxyphene—Dimetacrine—Carbamazepine—epilepsy syndrome	0.0129	0.0449	CrCrCtD
Dextropropoxyphene—Trimipramine—Oxcarbazepine—epilepsy syndrome	0.0124	0.0433	CrCrCtD
Dextropropoxyphene—Modafinil—Oxcarbazepine—epilepsy syndrome	0.0124	0.0433	CrCrCtD
Dextropropoxyphene—CYP2C8—Trimethadione—epilepsy syndrome	0.0123	0.043	CbGbCtD
Dextropropoxyphene—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.0119	0.0414	CrCrCtD
Dextropropoxyphene—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0115	0.0405	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.0115	0.0403	CbGbCtD
Dextropropoxyphene—CYP3A7—Carbamazepine—epilepsy syndrome	0.0115	0.0403	CbGbCtD
Dextropropoxyphene—Alimemazine—Carbamazepine—epilepsy syndrome	0.0112	0.0391	CrCrCtD
Dextropropoxyphene—Benzphetamine—Phenytoin—epilepsy syndrome	0.011	0.0383	CrCrCtD
Dextropropoxyphene—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.0103	0.036	CrCrCtD
Dextropropoxyphene—CYP3A7—Phenytoin—epilepsy syndrome	0.0103	0.0362	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.0103	0.0362	CbGbCtD
Dextropropoxyphene—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.0102	0.0355	CrCrCtD
Dextropropoxyphene—Diphenhydramine—Phenytoin—epilepsy syndrome	0.00976	0.034	CrCrCtD
Dextropropoxyphene—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.00939	0.0327	CrCrCtD
Dextropropoxyphene—CYP3A7—Phenobarbital—epilepsy syndrome	0.00918	0.0322	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00918	0.0322	CbGbCtD
Dextropropoxyphene—CYP3A7—Midazolam—epilepsy syndrome	0.00905	0.0318	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00905	0.0318	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.0087	0.0305	CbGbCtD
Dextropropoxyphene—CYP3A7—Diazepam—epilepsy syndrome	0.0087	0.0305	CbGbCtD
Dextropropoxyphene—CYP2C9—Trimethadione—epilepsy syndrome	0.00855	0.03	CbGbCtD
Dextropropoxyphene—CYP2C8—Carbamazepine—epilepsy syndrome	0.00828	0.0291	CbGbCtD
Dextropropoxyphene—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00804	0.0282	CbGbCtD
Dextropropoxyphene—CYP2C8—Primidone—epilepsy syndrome	0.00773	0.0271	CbGbCtD
Dextropropoxyphene—CYP2C8—Phenytoin—epilepsy syndrome	0.00743	0.0261	CbGbCtD
Dextropropoxyphene—CYP2C8—Propofol—epilepsy syndrome	0.00693	0.0243	CbGbCtD
Dextropropoxyphene—CYP2C8—Phenobarbital—epilepsy syndrome	0.00662	0.0232	CbGbCtD
Dextropropoxyphene—CYP2C8—Diazepam—epilepsy syndrome	0.00627	0.022	CbGbCtD
Dextropropoxyphene—CYP2C9—Carbamazepine—epilepsy syndrome	0.00578	0.0203	CbGbCtD
Dextropropoxyphene—CYP2C9—Primidone—epilepsy syndrome	0.00539	0.0189	CbGbCtD
Dextropropoxyphene—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00535	0.0188	CbGbCtD
Dextropropoxyphene—CYP2C9—Phenytoin—epilepsy syndrome	0.00518	0.0182	CbGbCtD
Dextropropoxyphene—CYP3A4—Trimethadione—epilepsy syndrome	0.00497	0.0175	CbGbCtD
Dextropropoxyphene—CYP3A4—Felbamate—epilepsy syndrome	0.00497	0.0175	CbGbCtD
Dextropropoxyphene—CYP2C8—Valproic Acid—epilepsy syndrome	0.00495	0.0174	CbGbCtD
Dextropropoxyphene—CYP2C9—Propofol—epilepsy syndrome	0.00483	0.017	CbGbCtD
Dextropropoxyphene—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00467	0.0164	CbGbCtD
Dextropropoxyphene—CYP2C9—Phenobarbital—epilepsy syndrome	0.00462	0.0162	CbGbCtD
Dextropropoxyphene—CYP2D6—Propofol—epilepsy syndrome	0.00442	0.0155	CbGbCtD
Dextropropoxyphene—CYP2C9—Diazepam—epilepsy syndrome	0.00438	0.0154	CbGbCtD
Dextropropoxyphene—CYP3A4—Clonazepam—epilepsy syndrome	0.00423	0.0148	CbGbCtD
Dextropropoxyphene—CYP3A4—Clobazam—epilepsy syndrome	0.00405	0.0142	CbGbCtD
Dextropropoxyphene—CYP2C9—Valproic Acid—epilepsy syndrome	0.00345	0.0121	CbGbCtD
Dextropropoxyphene—CYP3A4—Rufinamide—epilepsy syndrome	0.00345	0.0121	CbGbCtD
Dextropropoxyphene—CYP3A4—Carbamazepine—epilepsy syndrome	0.00336	0.0118	CbGbCtD
Dextropropoxyphene—CYP3A4—Primidone—epilepsy syndrome	0.00313	0.011	CbGbCtD
Dextropropoxyphene—CYP3A4—Phenytoin—epilepsy syndrome	0.00301	0.0106	CbGbCtD
Dextropropoxyphene—CYP3A4—Propofol—epilepsy syndrome	0.00281	0.00986	CbGbCtD
Dextropropoxyphene—CYP3A4—Acetazolamide—epilepsy syndrome	0.00268	0.00943	CbGbCtD
Dextropropoxyphene—CYP3A4—Phenobarbital—epilepsy syndrome	0.00268	0.00943	CbGbCtD
Dextropropoxyphene—CYP3A4—Midazolam—epilepsy syndrome	0.00265	0.00929	CbGbCtD
Dextropropoxyphene—CYP3A4—Diazepam—epilepsy syndrome	0.00254	0.00893	CbGbCtD
Dextropropoxyphene—CYP3A4—Zonisamide—epilepsy syndrome	0.00248	0.00872	CbGbCtD
Dextropropoxyphene—CYP3A4—Valproic Acid—epilepsy syndrome	0.00201	0.00704	CbGbCtD
Dextropropoxyphene—CYP3A4—Topiramate—epilepsy syndrome	0.00181	0.00636	CbGbCtD
Dextropropoxyphene—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00143	0.126	CbGeAlD
Dextropropoxyphene—OPRD1—ganglion—epilepsy syndrome	0.0013	0.115	CbGeAlD
Dextropropoxyphene—OPRM1—ganglion—epilepsy syndrome	0.000889	0.0782	CbGeAlD
Dextropropoxyphene—OPRD1—forebrain—epilepsy syndrome	0.000547	0.0481	CbGeAlD
Dextropropoxyphene—OPRK1—forebrain—epilepsy syndrome	0.000524	0.0461	CbGeAlD
Dextropropoxyphene—OPRD1—telencephalon—epilepsy syndrome	0.000503	0.0442	CbGeAlD
Dextropropoxyphene—OPRM1—brainstem—epilepsy syndrome	0.000386	0.034	CbGeAlD
Dextropropoxyphene—OPRM1—forebrain—epilepsy syndrome	0.000373	0.0328	CbGeAlD
Dextropropoxyphene—OPRM1—telencephalon—epilepsy syndrome	0.000343	0.0302	CbGeAlD
Dextropropoxyphene—OPRD1—head—epilepsy syndrome	0.000313	0.0275	CbGeAlD
Dextropropoxyphene—OPRK1—head—epilepsy syndrome	0.0003	0.0264	CbGeAlD
Dextropropoxyphene—OPRD1—nervous system—epilepsy syndrome	0.000297	0.0261	CbGeAlD
Dextropropoxyphene—OPRD1—central nervous system—epilepsy syndrome	0.000286	0.0251	CbGeAlD
Dextropropoxyphene—OPRK1—nervous system—epilepsy syndrome	0.000285	0.025	CbGeAlD
Dextropropoxyphene—OPRK1—central nervous system—epilepsy syndrome	0.000274	0.0241	CbGeAlD
Dextropropoxyphene—CYP2D6—hindbrain—epilepsy syndrome	0.00027	0.0238	CbGeAlD
Dextropropoxyphene—OPRK1—cerebellum—epilepsy syndrome	0.000268	0.0236	CbGeAlD
Dextropropoxyphene—OPRM1—midbrain—epilepsy syndrome	0.000246	0.0217	CbGeAlD
Dextropropoxyphene—OPRM1—spinal cord—epilepsy syndrome	0.00024	0.0211	CbGeAlD
Dextropropoxyphene—Disopyramide—KCND2—epilepsy syndrome	0.000234	0.0774	CrCbGaD
Dextropropoxyphene—OPRD1—brain—epilepsy syndrome	0.000227	0.02	CbGeAlD
Dextropropoxyphene—OPRK1—brain—epilepsy syndrome	0.000217	0.0191	CbGeAlD
Dextropropoxyphene—OPRM1—head—epilepsy syndrome	0.000213	0.0188	CbGeAlD
Dextropropoxyphene—OPRM1—nervous system—epilepsy syndrome	0.000202	0.0178	CbGeAlD
Dextropropoxyphene—OPRM1—central nervous system—epilepsy syndrome	0.000195	0.0171	CbGeAlD
Dextropropoxyphene—Bepridil—CACNA2D2—epilepsy syndrome	0.000155	0.0512	CrCbGaD
Dextropropoxyphene—CYP2D6—brainstem—epilepsy syndrome	0.000155	0.0136	CbGeAlD
Dextropropoxyphene—OPRM1—brain—epilepsy syndrome	0.000155	0.0136	CbGeAlD
Dextropropoxyphene—CYP2D6—forebrain—epilepsy syndrome	0.000149	0.0132	CbGeAlD
Dextropropoxyphene—Bepridil—CACNA1A—epilepsy syndrome	0.000147	0.0486	CrCbGaD
Dextropropoxyphene—CYP2D6—telencephalon—epilepsy syndrome	0.000137	0.0121	CbGeAlD
Dextropropoxyphene—Loperamide—CACNA1A—epilepsy syndrome	0.00013	0.043	CrCbGaD
Dextropropoxyphene—Methadyl Acetate—OPRM1—epilepsy syndrome	0.000109	0.0359	CrCbGaD
Dextropropoxyphene—Clidinium—CHRM3—epilepsy syndrome	9.99e-05	0.033	CrCbGaD
Dextropropoxyphene—Clidinium—CHRM1—epilepsy syndrome	9.32e-05	0.0308	CrCbGaD
Dextropropoxyphene—CYP2C8—brain—epilepsy syndrome	9.31e-05	0.00819	CbGeAlD
Dextropropoxyphene—Bepridil—CACNA1H—epilepsy syndrome	9.18e-05	0.0303	CrCbGaD
Dextropropoxyphene—Loperamide—POMC—epilepsy syndrome	9.03e-05	0.0298	CrCbGaD
Dextropropoxyphene—Bepridil—CACNA1D—epilepsy syndrome	8.67e-05	0.0286	CrCbGaD
Dextropropoxyphene—CYP2D6—head—epilepsy syndrome	8.56e-05	0.00753	CbGeAlD
Dextropropoxyphene—Isopropamide—CHRM3—epilepsy syndrome	8.5e-05	0.0281	CrCbGaD
Dextropropoxyphene—CYP3A4—nervous system—epilepsy syndrome	8.25e-05	0.00726	CbGeAlD
Dextropropoxyphene—CYP2D6—nervous system—epilepsy syndrome	8.11e-05	0.00714	CbGeAlD
Dextropropoxyphene—Mepenzolate—CHRM3—epilepsy syndrome	8.04e-05	0.0266	CrCbGaD
Dextropropoxyphene—CYP3A4—central nervous system—epilepsy syndrome	7.94e-05	0.00699	CbGeAlD
Dextropropoxyphene—Isopropamide—CHRM1—epilepsy syndrome	7.93e-05	0.0262	CrCbGaD
Dextropropoxyphene—Doxylamine—CHRM1—epilepsy syndrome	7.93e-05	0.0262	CrCbGaD
Dextropropoxyphene—CYP2D6—central nervous system—epilepsy syndrome	7.81e-05	0.00687	CbGeAlD
Dextropropoxyphene—CYP2D6—cerebellum—epilepsy syndrome	7.64e-05	0.00672	CbGeAlD
Dextropropoxyphene—Mepenzolate—CHRM1—epilepsy syndrome	7.49e-05	0.0248	CrCbGaD
Dextropropoxyphene—Diphenidol—CHRM3—epilepsy syndrome	7.04e-05	0.0233	CrCbGaD
Dextropropoxyphene—Orphenadrine—SCN9A—epilepsy syndrome	6.72e-05	0.0222	CrCbGaD
Dextropropoxyphene—Diphenidol—CHRM1—epilepsy syndrome	6.57e-05	0.0217	CrCbGaD
Dextropropoxyphene—Disopyramide—CHRM3—epilepsy syndrome	6.44e-05	0.0213	CrCbGaD
Dextropropoxyphene—CYP2D6—brain—epilepsy syndrome	6.2e-05	0.00546	CbGeAlD
Dextropropoxyphene—Orphenadrine—SCN4A—epilepsy syndrome	6.17e-05	0.0204	CrCbGaD
Dextropropoxyphene—Mepenzolate—CHRM2—epilepsy syndrome	6.12e-05	0.0202	CrCbGaD
Dextropropoxyphene—Disopyramide—CHRM1—epilepsy syndrome	6.01e-05	0.0198	CrCbGaD
Dextropropoxyphene—Asthenia—Fosphenytoin—epilepsy syndrome	5.6e-05	0.000557	CcSEcCtD
Dextropropoxyphene—Visual impairment—Gabapentin—epilepsy syndrome	5.6e-05	0.000557	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	5.59e-05	0.000557	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Phenytoin—epilepsy syndrome	5.59e-05	0.000557	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Clonazepam—epilepsy syndrome	5.59e-05	0.000556	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Lamotrigine—epilepsy syndrome	5.58e-05	0.000556	CcSEcCtD
Dextropropoxyphene—Somnolence—Lamotrigine—epilepsy syndrome	5.57e-05	0.000554	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	5.56e-05	0.000554	CcSEcCtD
Dextropropoxyphene—Constipation—Carbamazepine—epilepsy syndrome	5.54e-05	0.000552	CcSEcCtD
Dextropropoxyphene—Dizziness—Propofol—epilepsy syndrome	5.53e-05	0.000551	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Levetiracetam—epilepsy syndrome	5.53e-05	0.00055	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	5.52e-05	0.00055	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Diazepam—epilepsy syndrome	5.51e-05	0.000549	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Lamotrigine—epilepsy syndrome	5.51e-05	0.000549	CcSEcCtD
Dextropropoxyphene—Malnutrition—Pregabalin—epilepsy syndrome	5.51e-05	0.000549	CcSEcCtD
Dextropropoxyphene—Asthenia—Vigabatrin—epilepsy syndrome	5.45e-05	0.000543	CcSEcCtD
Dextropropoxyphene—Eye disorder—Gabapentin—epilepsy syndrome	5.43e-05	0.00054	CcSEcCtD
Dextropropoxyphene—Dizziness—Midazolam—epilepsy syndrome	5.41e-05	0.000539	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	5.41e-05	0.000538	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Clonazepam—epilepsy syndrome	5.4e-05	0.000538	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Gabapentin—epilepsy syndrome	5.39e-05	0.000536	CcSEcCtD
Dextropropoxyphene—Asthenia—Diazepam—epilepsy syndrome	5.37e-05	0.000535	CcSEcCtD
Dextropropoxyphene—Diphenidol—CHRM2—epilepsy syndrome	5.36e-05	0.0177	CrCbGaD
Dextropropoxyphene—Constipation—Lamotrigine—epilepsy syndrome	5.35e-05	0.000533	CcSEcCtD
Dextropropoxyphene—Nausea—Acetazolamide—epilepsy syndrome	5.35e-05	0.000533	CcSEcCtD
Dextropropoxyphene—Dizziness—Levetiracetam—epilepsy syndrome	5.34e-05	0.000532	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Carbamazepine—epilepsy syndrome	5.34e-05	0.000532	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Oxcarbazepine—epilepsy syndrome	5.34e-05	0.000531	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Fosphenytoin—epilepsy syndrome	5.34e-05	0.000531	CcSEcCtD
Dextropropoxyphene—Vomiting—Propofol—epilepsy syndrome	5.32e-05	0.000529	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	5.3e-05	0.000527	CcSEcCtD
Dextropropoxyphene—Fentanyl—OPRD1—epilepsy syndrome	5.28e-05	0.0174	CrCbGaD
Dextropropoxyphene—Rash—Propofol—epilepsy syndrome	5.27e-05	0.000525	CcSEcCtD
Dextropropoxyphene—Dermatitis—Propofol—epilepsy syndrome	5.27e-05	0.000525	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Gabapentin—epilepsy syndrome	5.24e-05	0.000522	CcSEcCtD
Dextropropoxyphene—Headache—Propofol—epilepsy syndrome	5.24e-05	0.000522	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Gabapentin—epilepsy syndrome	5.23e-05	0.000521	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Zonisamide—epilepsy syndrome	5.22e-05	0.00052	CcSEcCtD
Dextropropoxyphene—Vomiting—Midazolam—epilepsy syndrome	5.2e-05	0.000518	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Vigabatrin—epilepsy syndrome	5.2e-05	0.000518	CcSEcCtD
Dextropropoxyphene—Asthenia—Felbamate—epilepsy syndrome	5.2e-05	0.000517	CcSEcCtD
Dextropropoxyphene—Vision blurred—Pregabalin—epilepsy syndrome	5.19e-05	0.000517	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Lamotrigine—epilepsy syndrome	5.16e-05	0.000514	CcSEcCtD
Dextropropoxyphene—Rash—Midazolam—epilepsy syndrome	5.16e-05	0.000514	CcSEcCtD
Dextropropoxyphene—Dizziness—Fosphenytoin—epilepsy syndrome	5.16e-05	0.000513	CcSEcCtD
Dextropropoxyphene—Dermatitis—Midazolam—epilepsy syndrome	5.15e-05	0.000513	CcSEcCtD
Dextropropoxyphene—Vomiting—Levetiracetam—epilepsy syndrome	5.14e-05	0.000512	CcSEcCtD
Dextropropoxyphene—Discomfort—Valproic Acid—epilepsy syndrome	5.13e-05	0.000511	CcSEcCtD
Dextropropoxyphene—Headache—Midazolam—epilepsy syndrome	5.13e-05	0.00051	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Carbamazepine—epilepsy syndrome	5.12e-05	0.00051	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Diazepam—epilepsy syndrome	5.12e-05	0.00051	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	5.12e-05	0.00051	CcSEcCtD
Dextropropoxyphene—Rash—Levetiracetam—epilepsy syndrome	5.09e-05	0.000507	CcSEcCtD
Dextropropoxyphene—Dermatitis—Levetiracetam—epilepsy syndrome	5.09e-05	0.000507	CcSEcCtD
Dextropropoxyphene—Asthenia—Zonisamide—epilepsy syndrome	5.09e-05	0.000506	CcSEcCtD
Dextropropoxyphene—Loperamide—OPRD1—epilepsy syndrome	5.08e-05	0.0168	CrCbGaD
Dextropropoxyphene—Agitation—Pregabalin—epilepsy syndrome	5.07e-05	0.000504	CcSEcCtD
Dextropropoxyphene—Headache—Levetiracetam—epilepsy syndrome	5.06e-05	0.000504	CcSEcCtD
Dextropropoxyphene—Malnutrition—Gabapentin—epilepsy syndrome	5.05e-05	0.000503	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Clonazepam—epilepsy syndrome	5.03e-05	0.000501	CcSEcCtD
Dextropropoxyphene—Dizziness—Vigabatrin—epilepsy syndrome	5.03e-05	0.000501	CcSEcCtD
Dextropropoxyphene—Confusional state—Valproic Acid—epilepsy syndrome	5.02e-05	0.0005	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Phenytoin—epilepsy syndrome	5e-05	0.000498	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	4.97e-05	0.000495	CcSEcCtD
Dextropropoxyphene—Bradycardia—Topiramate—epilepsy syndrome	4.97e-05	0.000495	CcSEcCtD
Dextropropoxyphene—Nausea—Propofol—epilepsy syndrome	4.97e-05	0.000495	CcSEcCtD
Dextropropoxyphene—Vomiting—Fosphenytoin—epilepsy syndrome	4.96e-05	0.000494	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Felbamate—epilepsy syndrome	4.96e-05	0.000493	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Lamotrigine—epilepsy syndrome	4.95e-05	0.000493	CcSEcCtD
Dextropropoxyphene—Dizziness—Diazepam—epilepsy syndrome	4.95e-05	0.000493	CcSEcCtD
Dextropropoxyphene—Syncope—Pregabalin—epilepsy syndrome	4.94e-05	0.000492	CcSEcCtD
Dextropropoxyphene—Rash—Fosphenytoin—epilepsy syndrome	4.92e-05	0.00049	CcSEcCtD
Dextropropoxyphene—Dermatitis—Fosphenytoin—epilepsy syndrome	4.91e-05	0.000489	CcSEcCtD
Dextropropoxyphene—Disopyramide—CHRM2—epilepsy syndrome	4.9e-05	0.0162	CrCbGaD
Dextropropoxyphene—Asthenia—Clonazepam—epilepsy syndrome	4.9e-05	0.000488	CcSEcCtD
Dextropropoxyphene—Headache—Fosphenytoin—epilepsy syndrome	4.89e-05	0.000486	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Valproic Acid—epilepsy syndrome	4.88e-05	0.000486	CcSEcCtD
Dextropropoxyphene—Asthenia—Phenytoin—epilepsy syndrome	4.87e-05	0.000485	CcSEcCtD
Dextropropoxyphene—Nausea—Midazolam—epilepsy syndrome	4.86e-05	0.000484	CcSEcCtD
Dextropropoxyphene—Hallucination—Topiramate—epilepsy syndrome	4.86e-05	0.000484	CcSEcCtD
Dextropropoxyphene—Tachycardia—Valproic Acid—epilepsy syndrome	4.86e-05	0.000484	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Zonisamide—epilepsy syndrome	4.85e-05	0.000483	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Pregabalin—epilepsy syndrome	4.84e-05	0.000482	CcSEcCtD
Dextropropoxyphene—Asthenia—Oxcarbazepine—epilepsy syndrome	4.84e-05	0.000482	CcSEcCtD
Dextropropoxyphene—Vomiting—Vigabatrin—epilepsy syndrome	4.83e-05	0.000481	CcSEcCtD
Dextropropoxyphene—Nausea—Levetiracetam—epilepsy syndrome	4.8e-05	0.000478	CcSEcCtD
Dextropropoxyphene—Rash—Vigabatrin—epilepsy syndrome	4.79e-05	0.000477	CcSEcCtD
Dextropropoxyphene—Dizziness—Felbamate—epilepsy syndrome	4.79e-05	0.000477	CcSEcCtD
Dextropropoxyphene—Dermatitis—Vigabatrin—epilepsy syndrome	4.79e-05	0.000477	CcSEcCtD
Dextropropoxyphene—Convulsion—Pregabalin—epilepsy syndrome	4.78e-05	0.000475	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.77e-05	0.000475	CcSEcCtD
Dextropropoxyphene—Vision blurred—Gabapentin—epilepsy syndrome	4.76e-05	0.000474	CcSEcCtD
Dextropropoxyphene—Headache—Vigabatrin—epilepsy syndrome	4.76e-05	0.000474	CcSEcCtD
Dextropropoxyphene—Vomiting—Diazepam—epilepsy syndrome	4.76e-05	0.000474	CcSEcCtD
Dextropropoxyphene—Levomethadyl Acetate—OPRM1—epilepsy syndrome	4.72e-05	0.0156	CrCbGaD
Dextropropoxyphene—Rash—Diazepam—epilepsy syndrome	4.72e-05	0.00047	CcSEcCtD
Dextropropoxyphene—Dermatitis—Diazepam—epilepsy syndrome	4.71e-05	0.000469	CcSEcCtD
Dextropropoxyphene—Visual impairment—Topiramate—epilepsy syndrome	4.71e-05	0.000469	CcSEcCtD
Dextropropoxyphene—Dizziness—Zonisamide—epilepsy syndrome	4.69e-05	0.000467	CcSEcCtD
Dextropropoxyphene—Headache—Diazepam—epilepsy syndrome	4.69e-05	0.000467	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Clonazepam—epilepsy syndrome	4.68e-05	0.000466	CcSEcCtD
Dextropropoxyphene—Hypotension—Valproic Acid—epilepsy syndrome	4.65e-05	0.000463	CcSEcCtD
Dextropropoxyphene—Asthenia—Carbamazepine—epilepsy syndrome	4.65e-05	0.000463	CcSEcCtD
Dextropropoxyphene—Agitation—Gabapentin—epilepsy syndrome	4.64e-05	0.000462	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Phenytoin—epilepsy syndrome	4.64e-05	0.000462	CcSEcCtD
Dextropropoxyphene—Discomfort—Pregabalin—epilepsy syndrome	4.64e-05	0.000462	CcSEcCtD
Dextropropoxyphene—Nausea—Fosphenytoin—epilepsy syndrome	4.63e-05	0.000461	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.62e-05	0.00046	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.61e-05	0.000459	CcSEcCtD
Dextropropoxyphene—Vomiting—Felbamate—epilepsy syndrome	4.61e-05	0.000459	CcSEcCtD
Dextropropoxyphene—Rash—Felbamate—epilepsy syndrome	4.57e-05	0.000455	CcSEcCtD
Dextropropoxyphene—Eye disorder—Topiramate—epilepsy syndrome	4.56e-05	0.000454	CcSEcCtD
Dextropropoxyphene—Dermatitis—Felbamate—epilepsy syndrome	4.56e-05	0.000454	CcSEcCtD
Dextropropoxyphene—Headache—Felbamate—epilepsy syndrome	4.54e-05	0.000452	CcSEcCtD
Dextropropoxyphene—Confusional state—Pregabalin—epilepsy syndrome	4.54e-05	0.000452	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Topiramate—epilepsy syndrome	4.53e-05	0.000451	CcSEcCtD
Dextropropoxyphene—Syncope—Gabapentin—epilepsy syndrome	4.53e-05	0.000451	CcSEcCtD
Dextropropoxyphene—Dizziness—Clonazepam—epilepsy syndrome	4.52e-05	0.00045	CcSEcCtD
Dextropropoxyphene—Nausea—Vigabatrin—epilepsy syndrome	4.52e-05	0.00045	CcSEcCtD
Dextropropoxyphene—Orphenadrine—SCN1A—epilepsy syndrome	4.51e-05	0.0149	CrCbGaD
Dextropropoxyphene—Vomiting—Zonisamide—epilepsy syndrome	4.51e-05	0.000449	CcSEcCtD
Dextropropoxyphene—Insomnia—Valproic Acid—epilepsy syndrome	4.5e-05	0.000448	CcSEcCtD
Dextropropoxyphene—Asthenia—Lamotrigine—epilepsy syndrome	4.49e-05	0.000447	CcSEcCtD
Dextropropoxyphene—Dizziness—Phenytoin—epilepsy syndrome	4.49e-05	0.000447	CcSEcCtD
Dextropropoxyphene—Rash—Zonisamide—epilepsy syndrome	4.47e-05	0.000445	CcSEcCtD
Dextropropoxyphene—Dermatitis—Zonisamide—epilepsy syndrome	4.47e-05	0.000445	CcSEcCtD
Dextropropoxyphene—Dizziness—Oxcarbazepine—epilepsy syndrome	4.46e-05	0.000445	CcSEcCtD
Dextropropoxyphene—Nausea—Diazepam—epilepsy syndrome	4.45e-05	0.000443	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Gabapentin—epilepsy syndrome	4.44e-05	0.000442	CcSEcCtD
Dextropropoxyphene—Headache—Zonisamide—epilepsy syndrome	4.44e-05	0.000442	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Valproic Acid—epilepsy syndrome	4.44e-05	0.000442	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Carbamazepine—epilepsy syndrome	4.43e-05	0.000441	CcSEcCtD
Dextropropoxyphene—Shock—Pregabalin—epilepsy syndrome	4.43e-05	0.000441	CcSEcCtD
Dextropropoxyphene—Somnolence—Valproic Acid—epilepsy syndrome	4.42e-05	0.00044	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Topiramate—epilepsy syndrome	4.41e-05	0.000439	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Pregabalin—epilepsy syndrome	4.41e-05	0.000439	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Topiramate—epilepsy syndrome	4.4e-05	0.000438	CcSEcCtD
Dextropropoxyphene—Tachycardia—Pregabalin—epilepsy syndrome	4.39e-05	0.000437	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Valproic Acid—epilepsy syndrome	4.38e-05	0.000436	CcSEcCtD
Dextropropoxyphene—Convulsion—Gabapentin—epilepsy syndrome	4.38e-05	0.000436	CcSEcCtD
Dextropropoxyphene—Vomiting—Clonazepam—epilepsy syndrome	4.34e-05	0.000433	CcSEcCtD
Dextropropoxyphene—Vomiting—Phenytoin—epilepsy syndrome	4.32e-05	0.00043	CcSEcCtD
Dextropropoxyphene—Rash—Clonazepam—epilepsy syndrome	4.31e-05	0.000429	CcSEcCtD
Dextropropoxyphene—Dermatitis—Clonazepam—epilepsy syndrome	4.3e-05	0.000429	CcSEcCtD
Dextropropoxyphene—Nausea—Felbamate—epilepsy syndrome	4.3e-05	0.000428	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.3e-05	0.000428	CcSEcCtD
Dextropropoxyphene—Vomiting—Oxcarbazepine—epilepsy syndrome	4.29e-05	0.000427	CcSEcCtD
Dextropropoxyphene—Dizziness—Carbamazepine—epilepsy syndrome	4.28e-05	0.000427	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Lamotrigine—epilepsy syndrome	4.28e-05	0.000427	CcSEcCtD
Dextropropoxyphene—Headache—Clonazepam—epilepsy syndrome	4.28e-05	0.000426	CcSEcCtD
Dextropropoxyphene—Rash—Phenytoin—epilepsy syndrome	4.28e-05	0.000426	CcSEcCtD
Dextropropoxyphene—Dermatitis—Phenytoin—epilepsy syndrome	4.28e-05	0.000426	CcSEcCtD
Dextropropoxyphene—Rash—Oxcarbazepine—epilepsy syndrome	4.26e-05	0.000424	CcSEcCtD
Dextropropoxyphene—Constipation—Valproic Acid—epilepsy syndrome	4.25e-05	0.000424	CcSEcCtD
Dextropropoxyphene—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.25e-05	0.000423	CcSEcCtD
Dextropropoxyphene—Headache—Phenytoin—epilepsy syndrome	4.25e-05	0.000423	CcSEcCtD
Dextropropoxyphene—Malnutrition—Topiramate—epilepsy syndrome	4.25e-05	0.000423	CcSEcCtD
Dextropropoxyphene—Discomfort—Gabapentin—epilepsy syndrome	4.25e-05	0.000423	CcSEcCtD
Dextropropoxyphene—Headache—Oxcarbazepine—epilepsy syndrome	4.23e-05	0.000421	CcSEcCtD
Dextropropoxyphene—Nausea—Zonisamide—epilepsy syndrome	4.21e-05	0.000419	CcSEcCtD
Dextropropoxyphene—Hypotension—Pregabalin—epilepsy syndrome	4.2e-05	0.000419	CcSEcCtD
Dextropropoxyphene—Confusional state—Gabapentin—epilepsy syndrome	4.16e-05	0.000414	CcSEcCtD
Dextropropoxyphene—Dizziness—Lamotrigine—epilepsy syndrome	4.14e-05	0.000412	CcSEcCtD
Dextropropoxyphene—Vomiting—Carbamazepine—epilepsy syndrome	4.12e-05	0.00041	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.1e-05	0.000408	CcSEcCtD
Dextropropoxyphene—Rash—Carbamazepine—epilepsy syndrome	4.09e-05	0.000407	CcSEcCtD
Dextropropoxyphene—Dermatitis—Carbamazepine—epilepsy syndrome	4.08e-05	0.000406	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.07e-05	0.000405	CcSEcCtD
Dextropropoxyphene—Insomnia—Pregabalin—epilepsy syndrome	4.07e-05	0.000405	CcSEcCtD
Dextropropoxyphene—Nausea—Clonazepam—epilepsy syndrome	4.06e-05	0.000404	CcSEcCtD
Dextropropoxyphene—Headache—Carbamazepine—epilepsy syndrome	4.06e-05	0.000404	CcSEcCtD
Dextropropoxyphene—Shock—Gabapentin—epilepsy syndrome	4.06e-05	0.000404	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Gabapentin—epilepsy syndrome	4.05e-05	0.000403	CcSEcCtD
Dextropropoxyphene—Fentanyl—OPRM1—epilepsy syndrome	4.04e-05	0.0133	CrCbGaD
Dextropropoxyphene—Nausea—Phenytoin—epilepsy syndrome	4.03e-05	0.000401	CcSEcCtD
Dextropropoxyphene—Tachycardia—Gabapentin—epilepsy syndrome	4.03e-05	0.000401	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Pregabalin—epilepsy syndrome	4.01e-05	0.000399	CcSEcCtD
Dextropropoxyphene—Nausea—Oxcarbazepine—epilepsy syndrome	4.01e-05	0.000399	CcSEcCtD
Dextropropoxyphene—Vision blurred—Topiramate—epilepsy syndrome	4.01e-05	0.000399	CcSEcCtD
Dextropropoxyphene—Somnolence—Pregabalin—epilepsy syndrome	4e-05	0.000398	CcSEcCtD
Dextropropoxyphene—Vomiting—Lamotrigine—epilepsy syndrome	3.98e-05	0.000396	CcSEcCtD
Dextropropoxyphene—Rash—Lamotrigine—epilepsy syndrome	3.95e-05	0.000393	CcSEcCtD
Dextropropoxyphene—Dermatitis—Lamotrigine—epilepsy syndrome	3.94e-05	0.000393	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Valproic Acid—epilepsy syndrome	3.93e-05	0.000392	CcSEcCtD
Dextropropoxyphene—Headache—Lamotrigine—epilepsy syndrome	3.92e-05	0.000391	CcSEcCtD
Dextropropoxyphene—Agitation—Topiramate—epilepsy syndrome	3.91e-05	0.000389	CcSEcCtD
Dextropropoxyphene—Loperamide—OPRM1—epilepsy syndrome	3.89e-05	0.0129	CrCbGaD
Dextropropoxyphene—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.88e-05	0.000387	CcSEcCtD
Dextropropoxyphene—Hypotension—Gabapentin—epilepsy syndrome	3.85e-05	0.000384	CcSEcCtD
Dextropropoxyphene—Nausea—Carbamazepine—epilepsy syndrome	3.85e-05	0.000383	CcSEcCtD
Dextropropoxyphene—Constipation—Pregabalin—epilepsy syndrome	3.85e-05	0.000383	CcSEcCtD
Dextropropoxyphene—Syncope—Topiramate—epilepsy syndrome	3.81e-05	0.00038	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Topiramate—epilepsy syndrome	3.74e-05	0.000372	CcSEcCtD
Dextropropoxyphene—Insomnia—Gabapentin—epilepsy syndrome	3.73e-05	0.000371	CcSEcCtD
Dextropropoxyphene—Nausea—Lamotrigine—epilepsy syndrome	3.72e-05	0.00037	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Pregabalin—epilepsy syndrome	3.71e-05	0.000369	CcSEcCtD
Dextropropoxyphene—Convulsion—Topiramate—epilepsy syndrome	3.68e-05	0.000367	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.68e-05	0.000366	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Gabapentin—epilepsy syndrome	3.68e-05	0.000366	CcSEcCtD
Dextropropoxyphene—Somnolence—Gabapentin—epilepsy syndrome	3.67e-05	0.000365	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.67e-05	0.000365	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Gabapentin—epilepsy syndrome	3.63e-05	0.000362	CcSEcCtD
Dextropropoxyphene—Methadone—OPRD1—epilepsy syndrome	3.62e-05	0.012	CrCbGaD
Dextropropoxyphene—Discomfort—Topiramate—epilepsy syndrome	3.58e-05	0.000356	CcSEcCtD
Dextropropoxyphene—Asthenia—Valproic Acid—epilepsy syndrome	3.57e-05	0.000355	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.56e-05	0.000355	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Pregabalin—epilepsy syndrome	3.56e-05	0.000354	CcSEcCtD
Dextropropoxyphene—Constipation—Gabapentin—epilepsy syndrome	3.53e-05	0.000351	CcSEcCtD
Dextropropoxyphene—Confusional state—Topiramate—epilepsy syndrome	3.5e-05	0.000348	CcSEcCtD
Dextropropoxyphene—Shock—Topiramate—epilepsy syndrome	3.41e-05	0.00034	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Valproic Acid—epilepsy syndrome	3.4e-05	0.000339	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Topiramate—epilepsy syndrome	3.4e-05	0.000339	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Gabapentin—epilepsy syndrome	3.4e-05	0.000338	CcSEcCtD
Dextropropoxyphene—Tachycardia—Topiramate—epilepsy syndrome	3.39e-05	0.000337	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.37e-05	0.000336	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Pregabalin—epilepsy syndrome	3.31e-05	0.00033	CcSEcCtD
Dextropropoxyphene—Dizziness—Valproic Acid—epilepsy syndrome	3.29e-05	0.000328	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Gabapentin—epilepsy syndrome	3.26e-05	0.000325	CcSEcCtD
Dextropropoxyphene—Hypotension—Topiramate—epilepsy syndrome	3.24e-05	0.000323	CcSEcCtD
Dextropropoxyphene—Asthenia—Pregabalin—epilepsy syndrome	3.23e-05	0.000321	CcSEcCtD
Dextropropoxyphene—Vomiting—Valproic Acid—epilepsy syndrome	3.16e-05	0.000315	CcSEcCtD
Dextropropoxyphene—Insomnia—Topiramate—epilepsy syndrome	3.14e-05	0.000313	CcSEcCtD
Dextropropoxyphene—Rash—Valproic Acid—epilepsy syndrome	3.14e-05	0.000312	CcSEcCtD
Dextropropoxyphene—Dermatitis—Valproic Acid—epilepsy syndrome	3.13e-05	0.000312	CcSEcCtD
Dextropropoxyphene—Headache—Valproic Acid—epilepsy syndrome	3.12e-05	0.00031	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Topiramate—epilepsy syndrome	3.09e-05	0.000308	CcSEcCtD
Dextropropoxyphene—Somnolence—Topiramate—epilepsy syndrome	3.09e-05	0.000307	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Pregabalin—epilepsy syndrome	3.08e-05	0.000306	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Topiramate—epilepsy syndrome	3.05e-05	0.000304	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Gabapentin—epilepsy syndrome	3.04e-05	0.000303	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3e-05	0.000298	CcSEcCtD
Dextropropoxyphene—Dizziness—Pregabalin—epilepsy syndrome	2.97e-05	0.000296	CcSEcCtD
Dextropropoxyphene—Constipation—Topiramate—epilepsy syndrome	2.97e-05	0.000295	CcSEcCtD
Dextropropoxyphene—Asthenia—Gabapentin—epilepsy syndrome	2.96e-05	0.000295	CcSEcCtD
Dextropropoxyphene—Nausea—Valproic Acid—epilepsy syndrome	2.96e-05	0.000294	CcSEcCtD
Dextropropoxyphene—Vomiting—Pregabalin—epilepsy syndrome	2.86e-05	0.000285	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Topiramate—epilepsy syndrome	2.86e-05	0.000285	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.84e-05	0.000283	CcSEcCtD
Dextropropoxyphene—Rash—Pregabalin—epilepsy syndrome	2.84e-05	0.000282	CcSEcCtD
Dextropropoxyphene—Dermatitis—Pregabalin—epilepsy syndrome	2.83e-05	0.000282	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Gabapentin—epilepsy syndrome	2.82e-05	0.000281	CcSEcCtD
Dextropropoxyphene—Headache—Pregabalin—epilepsy syndrome	2.82e-05	0.000281	CcSEcCtD
Dextropropoxyphene—Tripelennamine—CYP2D6—epilepsy syndrome	2.82e-05	0.00931	CrCbGaD
Dextropropoxyphene—Methadone—OPRM1—epilepsy syndrome	2.77e-05	0.00915	CrCbGaD
Dextropropoxyphene—Abdominal pain—Topiramate—epilepsy syndrome	2.74e-05	0.000273	CcSEcCtD
Dextropropoxyphene—Dizziness—Gabapentin—epilepsy syndrome	2.73e-05	0.000272	CcSEcCtD
Dextropropoxyphene—Nausea—Pregabalin—epilepsy syndrome	2.67e-05	0.000266	CcSEcCtD
Dextropropoxyphene—Vomiting—Gabapentin—epilepsy syndrome	2.62e-05	0.000261	CcSEcCtD
Dextropropoxyphene—Rash—Gabapentin—epilepsy syndrome	2.6e-05	0.000259	CcSEcCtD
Dextropropoxyphene—Dermatitis—Gabapentin—epilepsy syndrome	2.6e-05	0.000259	CcSEcCtD
Dextropropoxyphene—Benzphetamine—ADRA2A—epilepsy syndrome	2.59e-05	0.00854	CrCbGaD
Dextropropoxyphene—Headache—Gabapentin—epilepsy syndrome	2.58e-05	0.000257	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Topiramate—epilepsy syndrome	2.56e-05	0.000255	CcSEcCtD
Dextropropoxyphene—Asthenia—Topiramate—epilepsy syndrome	2.49e-05	0.000248	CcSEcCtD
Dextropropoxyphene—Phenoxybenzamine—ADRA2A—epilepsy syndrome	2.47e-05	0.00817	CrCbGaD
Dextropropoxyphene—Nausea—Gabapentin—epilepsy syndrome	2.45e-05	0.000244	CcSEcCtD
Dextropropoxyphene—Diphenhydramine—CHRM2—epilepsy syndrome	2.43e-05	0.00802	CrCbGaD
Dextropropoxyphene—Diarrhoea—Topiramate—epilepsy syndrome	2.37e-05	0.000236	CcSEcCtD
Dextropropoxyphene—Orphenadrine—CHRM2—epilepsy syndrome	2.3e-05	0.00759	CrCbGaD
Dextropropoxyphene—Dizziness—Topiramate—epilepsy syndrome	2.29e-05	0.000228	CcSEcCtD
Dextropropoxyphene—Vomiting—Topiramate—epilepsy syndrome	2.21e-05	0.00022	CcSEcCtD
Dextropropoxyphene—Rash—Topiramate—epilepsy syndrome	2.19e-05	0.000218	CcSEcCtD
Dextropropoxyphene—Dermatitis—Topiramate—epilepsy syndrome	2.19e-05	0.000218	CcSEcCtD
Dextropropoxyphene—Headache—Topiramate—epilepsy syndrome	2.17e-05	0.000216	CcSEcCtD
Dextropropoxyphene—Modafinil—CYP2C19—epilepsy syndrome	2.16e-05	0.00713	CrCbGaD
Dextropropoxyphene—Trimipramine—ADRA2A—epilepsy syndrome	2.11e-05	0.00697	CrCbGaD
Dextropropoxyphene—Tamoxifen—ABCC2—epilepsy syndrome	2.1e-05	0.00694	CrCbGaD
Dextropropoxyphene—Nausea—Topiramate—epilepsy syndrome	2.06e-05	0.000205	CcSEcCtD
Dextropropoxyphene—Toremifene—ABCB1—epilepsy syndrome	1.93e-05	0.00639	CrCbGaD
Dextropropoxyphene—Propafenone—CYP2D6—epilepsy syndrome	1.91e-05	0.00631	CrCbGaD
Dextropropoxyphene—Tamoxifen—ABCG2—epilepsy syndrome	1.86e-05	0.00613	CrCbGaD
Dextropropoxyphene—Phenylbutazone—PTGS2—epilepsy syndrome	1.71e-05	0.00567	CrCbGaD
Dextropropoxyphene—Bepridil—CYP2D6—epilepsy syndrome	1.7e-05	0.00562	CrCbGaD
Dextropropoxyphene—Trimipramine—SLC6A4—epilepsy syndrome	1.61e-05	0.00532	CrCbGaD
Dextropropoxyphene—Trimipramine—CYP2C19—epilepsy syndrome	1.53e-05	0.00504	CrCbGaD
Dextropropoxyphene—Loperamide—CYP2D6—epilepsy syndrome	1.51e-05	0.00498	CrCbGaD
Dextropropoxyphene—Diphenhydramine—CYP2C19—epilepsy syndrome	1.5e-05	0.00495	CrCbGaD
Dextropropoxyphene—Tamoxifen—CYP2C19—epilepsy syndrome	1.46e-05	0.00482	CrCbGaD
Dextropropoxyphene—Methadone—CYP2C19—epilepsy syndrome	1.45e-05	0.00478	CrCbGaD
Dextropropoxyphene—Propafenone—ABCB1—epilepsy syndrome	1.36e-05	0.0045	CrCbGaD
Dextropropoxyphene—Trimipramine—HTR2A—epilepsy syndrome	1.24e-05	0.00409	CrCbGaD
Dextropropoxyphene—Bepridil—ABCB1—epilepsy syndrome	1.21e-05	0.00401	CrCbGaD
Dextropropoxyphene—Trimipramine—CYP2D6—epilepsy syndrome	1.13e-05	0.00374	CrCbGaD
Dextropropoxyphene—Fentanyl—ABCB1—epilepsy syndrome	1.12e-05	0.00369	CrCbGaD
Dextropropoxyphene—Diphenhydramine—CYP2D6—epilepsy syndrome	1.11e-05	0.00367	CrCbGaD
Dextropropoxyphene—Tamoxifen—CYP2D6—epilepsy syndrome	1.08e-05	0.00357	CrCbGaD
Dextropropoxyphene—Loperamide—ABCB1—epilepsy syndrome	1.08e-05	0.00355	CrCbGaD
Dextropropoxyphene—Methadone—CYP2D6—epilepsy syndrome	1.07e-05	0.00354	CrCbGaD
Dextropropoxyphene—Trimipramine—ABCB1—epilepsy syndrome	8.08e-06	0.00267	CrCbGaD
Dextropropoxyphene—Tamoxifen—ABCB1—epilepsy syndrome	7.72e-06	0.00255	CrCbGaD
Dextropropoxyphene—Methadone—ABCB1—epilepsy syndrome	7.66e-06	0.00253	CrCbGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CCL2—epilepsy syndrome	4.4e-06	0.000102	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.4e-06	0.000102	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	4.4e-06	0.000102	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	4.37e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	4.36e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PLAT—epilepsy syndrome	4.35e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HES1—epilepsy syndrome	4.32e-06	0.0001	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ADSL—epilepsy syndrome	4.31e-06	9.97e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—COX3—epilepsy syndrome	4.28e-06	9.92e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ADSL—epilepsy syndrome	4.27e-06	9.89e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	4.27e-06	9.88e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GLUL—epilepsy syndrome	4.22e-06	9.78e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	4.22e-06	9.78e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—TH—epilepsy syndrome	4.21e-06	9.74e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—FYN—epilepsy syndrome	4.2e-06	9.72e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CXCL12—epilepsy syndrome	4.2e-06	9.72e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	4.2e-06	9.72e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—POMC—epilepsy syndrome	4.19e-06	9.7e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GLUL—epilepsy syndrome	4.19e-06	9.7e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—S100B—epilepsy syndrome	4.18e-06	9.69e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—H2AFX—epilepsy syndrome	4.18e-06	9.69e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	4.18e-06	9.67e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MEF2C—epilepsy syndrome	4.17e-06	9.67e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	4.16e-06	9.64e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	4.15e-06	9.6e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	4.15e-06	9.6e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	4.14e-06	9.6e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SOCS3—epilepsy syndrome	4.14e-06	9.6e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CDC42—epilepsy syndrome	4.13e-06	9.57e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CNR1—epilepsy syndrome	4.12e-06	9.54e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—JUNB—epilepsy syndrome	4.12e-06	9.54e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	4.11e-06	9.52e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PLCB1—epilepsy syndrome	4.1e-06	9.51e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	4.06e-06	9.41e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PFKL—epilepsy syndrome	4.06e-06	9.41e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	4.06e-06	9.41e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	4.06e-06	9.41e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	4.06e-06	9.41e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—YWHAZ—epilepsy syndrome	4.03e-06	9.34e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HTR7—epilepsy syndrome	4.02e-06	9.31e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—AVP—epilepsy syndrome	4e-06	9.27e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—NGF—epilepsy syndrome	3.99e-06	9.24e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HBEGF—epilepsy syndrome	3.9e-06	9.04e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCR5—epilepsy syndrome	3.88e-06	8.99e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	3.88e-06	8.98e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.86e-06	8.94e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	3.84e-06	8.9e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—AKT3—epilepsy syndrome	3.83e-06	8.87e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—POMC—epilepsy syndrome	3.8e-06	8.81e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HTR2A—epilepsy syndrome	3.8e-06	8.8e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HES1—epilepsy syndrome	3.78e-06	8.77e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.78e-06	8.76e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—AQP1—epilepsy syndrome	3.76e-06	8.72e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ADAM10—epilepsy syndrome	3.74e-06	8.66e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—AQP1—epilepsy syndrome	3.73e-06	8.64e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CCL2—epilepsy syndrome	3.72e-06	8.62e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.71e-06	8.6e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.71e-06	8.6e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.71e-06	8.6e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—FYN—epilepsy syndrome	3.68e-06	8.52e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—H2AFX—epilepsy syndrome	3.67e-06	8.49e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MEF2C—epilepsy syndrome	3.66e-06	8.48e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TSC2—epilepsy syndrome	3.61e-06	8.36e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—AGT—epilepsy syndrome	3.6e-06	8.35e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.58e-06	8.3e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.58e-06	8.28e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—YWHAZ—epilepsy syndrome	3.54e-06	8.19e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—S100B—epilepsy syndrome	3.54e-06	8.19e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—APOE—epilepsy syndrome	3.53e-06	8.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	3.51e-06	8.13e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SOCS3—epilepsy syndrome	3.5e-06	8.11e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—NGF—epilepsy syndrome	3.5e-06	8.1e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CDC42—epilepsy syndrome	3.49e-06	8.09e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CAT—epilepsy syndrome	3.46e-06	8.02e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—KDR—epilepsy syndrome	3.46e-06	8.01e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.45e-06	8e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.45e-06	8e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	3.4e-06	7.88e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	3.4e-06	7.88e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCR5—epilepsy syndrome	3.4e-06	7.88e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—AVP—epilepsy syndrome	3.38e-06	7.83e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	3.38e-06	7.83e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	3.37e-06	7.82e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	3.37e-06	7.82e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	3.37e-06	7.8e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HTR2A—epilepsy syndrome	3.33e-06	7.71e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PRKCB—epilepsy syndrome	3.33e-06	7.71e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL6ST—epilepsy syndrome	3.32e-06	7.68e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	3.29e-06	7.63e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	3.27e-06	7.58e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.25e-06	7.53e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.25e-06	7.52e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HES1—epilepsy syndrome	3.2e-06	7.41e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TSC2—epilepsy syndrome	3.16e-06	7.33e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—AGT—epilepsy syndrome	3.16e-06	7.32e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3.16e-06	7.32e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.14e-06	7.28e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GPX1—epilepsy syndrome	3.13e-06	7.25e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	3.11e-06	7.2e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	3.1e-06	7.18e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—APOE—epilepsy syndrome	3.1e-06	7.17e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	3.09e-06	7.16e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.08e-06	7.13e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.08e-06	7.13e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.08e-06	7.13e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—POMC—epilepsy syndrome	3.03e-06	7.02e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—KDR—epilepsy syndrome	3.03e-06	7.02e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.99e-06	6.92e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCL2—epilepsy syndrome	2.97e-06	6.87e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.96e-06	6.86e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	2.96e-06	6.85e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	2.95e-06	6.84e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.94e-06	6.8e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.94e-06	6.8e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PRKCB—epilepsy syndrome	2.92e-06	6.76e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL6ST—epilepsy syndrome	2.91e-06	6.73e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	2.88e-06	6.66e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.87e-06	6.66e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.82e-06	6.52e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	2.81e-06	6.52e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	2.81e-06	6.51e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—BCHE—epilepsy syndrome	2.8e-06	6.49e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.77e-06	6.43e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.76e-06	6.39e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.75e-06	6.37e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—AGT—epilepsy syndrome	2.75e-06	6.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.71e-06	6.28e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.7e-06	6.26e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—APOE—epilepsy syndrome	2.69e-06	6.23e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.69e-06	6.22e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—FGF2—epilepsy syndrome	2.68e-06	6.21e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.68e-06	6.21e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	2.67e-06	6.19e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	2.67e-06	6.19e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	2.67e-06	6.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.66e-06	6.17e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—POMC—epilepsy syndrome	2.66e-06	6.16e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.64e-06	6.13e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	2.64e-06	6.12e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—TH—epilepsy syndrome	2.63e-06	6.1e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	2.62e-06	6.06e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCL2—epilepsy syndrome	2.6e-06	6.03e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.59e-06	6e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	2.56e-06	5.94e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.53e-06	5.87e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—RELA—epilepsy syndrome	2.49e-06	5.77e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	2.47e-06	5.71e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.46e-06	5.7e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	2.46e-06	5.69e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MTOR—epilepsy syndrome	2.44e-06	5.65e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.41e-06	5.59e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.4e-06	5.57e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—FGF2—epilepsy syndrome	2.35e-06	5.45e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—POMC—epilepsy syndrome	2.31e-06	5.35e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.31e-06	5.35e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.3e-06	5.33e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.29e-06	5.3e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.28e-06	5.28e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.27e-06	5.25e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	2.25e-06	5.21e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CASP3—epilepsy syndrome	2.25e-06	5.2e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.23e-06	5.15e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.23e-06	5.15e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	2.2e-06	5.09e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	2.2e-06	5.09e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.19e-06	5.08e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—RELA—epilepsy syndrome	2.18e-06	5.06e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—JUN—epilepsy syndrome	2.18e-06	5.05e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.17e-06	5.04e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.17e-06	5.03e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CAT—epilepsy syndrome	2.17e-06	5.02e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—TH—epilepsy syndrome	2.16e-06	5.01e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.15e-06	4.98e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—TH—epilepsy syndrome	2.14e-06	4.96e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MTOR—epilepsy syndrome	2.14e-06	4.96e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MMP9—epilepsy syndrome	2.12e-06	4.92e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.11e-06	4.89e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	2.11e-06	4.89e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ALB—epilepsy syndrome	2.11e-06	4.88e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—AKT1—epilepsy syndrome	2.06e-06	4.77e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	1.99e-06	4.6e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.99e-06	4.6e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CASP3—epilepsy syndrome	1.97e-06	4.56e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.96e-06	4.54e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SRC—epilepsy syndrome	1.96e-06	4.53e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—JUN—epilepsy syndrome	1.91e-06	4.43e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—VEGFA—epilepsy syndrome	1.91e-06	4.41e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MMP9—epilepsy syndrome	1.86e-06	4.31e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	1.84e-06	4.27e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.84e-06	4.27e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.81e-06	4.2e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	1.81e-06	4.19e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—AKT1—epilepsy syndrome	1.8e-06	4.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.8e-06	4.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.79e-06	4.14e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.78e-06	4.12e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.77e-06	4.1e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.76e-06	4.09e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.76e-06	4.07e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.73e-06	4.01e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.72e-06	3.98e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.72e-06	3.98e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SRC—epilepsy syndrome	1.72e-06	3.97e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.68e-06	3.9e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.68e-06	3.89e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—VEGFA—epilepsy syndrome	1.67e-06	3.87e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.66e-06	3.85e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	1.62e-06	3.74e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.61e-06	3.73e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.6e-06	3.7e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.59e-06	3.67e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	1.57e-06	3.64e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.53e-06	3.53e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.51e-06	3.5e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.5e-06	3.48e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	1.45e-06	3.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.45e-06	3.35e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.43e-06	3.32e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.42e-06	3.29e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—TH—epilepsy syndrome	1.41e-06	3.27e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.41e-06	3.27e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.41e-06	3.27e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.4e-06	3.24e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.38e-06	3.2e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.37e-06	3.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.32e-06	3.06e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—AKT1—epilepsy syndrome	1.22e-06	2.82e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.19e-06	2.75e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.18e-06	2.73e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.18e-06	2.73e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.16e-06	2.7e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.15e-06	2.67e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.13e-06	2.62e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.08e-06	2.51e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.07e-06	2.49e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—AKT1—epilepsy syndrome	1.07e-06	2.47e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.05e-06	2.44e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	9.48e-07	2.2e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	9.4e-07	2.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—AKT1—epilepsy syndrome	9.27e-07	2.15e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—AGT—epilepsy syndrome	9.23e-07	2.14e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—APOE—epilepsy syndrome	9.04e-07	2.09e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	9.01e-07	2.09e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—POMC—epilepsy syndrome	7.77e-07	1.8e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALB—epilepsy syndrome	7.08e-07	1.64e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	6.2e-07	1.44e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—AKT1—epilepsy syndrome	5.8e-07	1.34e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—AKT1—epilepsy syndrome	4.76e-07	1.1e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—AKT1—epilepsy syndrome	4.72e-07	1.09e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.11e-07	7.21e-06	CbGpPWpGaD
